Bowel (colorectal) cancer, Rectal cancer
Results
Phase 3
This trial compared capecitabine (Xeloda) and oxaliplatin (Eloxatin) chemotherapy with no chemotherapy after surgery for rectal cancer. This trial was supported by Cancer Research UK.
Recruitment start: 1 November 2004
Recruitment end: 30 April 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr R Glynne-Jones
Cancer Research UK
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUK/03/009.
Last reviewed: 18 November 2014
CRUK internal database number: 340
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
